Close Menu

NEW YORK – Biolytical has been awarded funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to develop a test for antibodies to SARS-CoV-2. 

The award totals C$633,000 ($460,000) and will support development of a test on the firm's INSTI platform. The platform performs 60-second antibody testing directly from finger stick whole-blood samples, as previously reported.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.